US DMFs Filed
USA (Orange Book)
PharmaCompass offers a list of Clindamycin Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clindamycin Phosphate manufacturer or Clindamycin Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clindamycin Phosphate manufacturer or Clindamycin Phosphate supplier.
PharmaCompass also assists you with knowing the Clindamycin Phosphate API Price utilized in the formulation of products. Clindamycin Phosphate API Price is not always fixed or binding as the Clindamycin Phosphate Price is obtained through a variety of data sources. The Clindamycin Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clindamycin Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clindamycin Phosphate, including repackagers and relabelers. The FDA regulates Clindamycin Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clindamycin Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
CLICK HERE to find a list of Clindamycin Phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clindamycin Phosphate supplier is an individual or a company that provides Clindamycin Phosphate active pharmaceutical ingredient (API) or Clindamycin Phosphate finished formulations upon request. The Clindamycin Phosphate suppliers may include Clindamycin Phosphate API manufacturers, exporters, distributors and traders.
CLICK HERE to find a list of Clindamycin Phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clindamycin Phosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Clindamycin Phosphate active pharmaceutical ingredient (API) in detail. Different forms of Clindamycin Phosphate DMFs exist exist since differing nations have different regulations, such as Clindamycin Phosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clindamycin Phosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Clindamycin Phosphate USDMF includes data on Clindamycin Phosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clindamycin Phosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
CLICK HERE to find a list of Clindamycin Phosphate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Clindamycin Phosphate Drug Master File in Japan (Clindamycin Phosphate JDMF) empowers Clindamycin Phosphate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Clindamycin Phosphate JDMF during the approval evaluation for pharmaceutical products. At the time of Clindamycin Phosphate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
CLICK HERE to find a list of Clindamycin Phosphate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clindamycin Phosphate Drug Master File in Korea (Clindamycin Phosphate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clindamycin Phosphate. The MFDS reviews the Clindamycin Phosphate KDMF as part of the drug registration process and uses the information provided in the Clindamycin Phosphate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clindamycin Phosphate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clindamycin Phosphate API can apply through the Korea Drug Master File (KDMF).
CLICK HERE to find a list of Clindamycin Phosphate suppliers with KDMF on PharmaCompass.
A Clindamycin Phosphate CEP of the European Pharmacopoeia monograph is often referred to as a Clindamycin Phosphate Certificate of Suitability (COS). The purpose of a Clindamycin Phosphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clindamycin Phosphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clindamycin Phosphate to their clients by showing that a Clindamycin Phosphate CEP has been issued for it. The manufacturer submits a Clindamycin Phosphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clindamycin Phosphate CEP holder for the record. Additionally, the data presented in the Clindamycin Phosphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clindamycin Phosphate DMF.
A Clindamycin Phosphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clindamycin Phosphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
CLICK HERE to find a list of Clindamycin Phosphate suppliers with CEP (COS) on PharmaCompass.
A Clindamycin Phosphate written confirmation (Clindamycin Phosphate WC) is an official document issued by a regulatory agency to a Clindamycin Phosphate manufacturer, verifying that the manufacturing facility of a Clindamycin Phosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clindamycin Phosphate APIs or Clindamycin Phosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clindamycin Phosphate WC (written confirmation) as part of the regulatory process.
CLICK HERE to find a list of Clindamycin Phosphate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clindamycin Phosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clindamycin Phosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clindamycin Phosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clindamycin Phosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clindamycin Phosphate NDC to their finished compounded human drug products, they may choose to do so.
CLICK HERE to find a list of Clindamycin Phosphate suppliers with NDC on PharmaCompass.
Clindamycin Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clindamycin Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clindamycin Phosphate GMP manufacturer or Clindamycin Phosphate GMP API supplier for your needs.
A Clindamycin Phosphate CoA (Certificate of Analysis) is a formal document that attests to Clindamycin Phosphate's compliance with Clindamycin Phosphate specifications and serves as a tool for batch-level quality control.
Clindamycin Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Clindamycin Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clindamycin Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clindamycin Phosphate EP), Clindamycin Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clindamycin Phosphate USP).